Dumoulin, D.W.; Cornelissen, R.; Bezemer, K.; Baart, S.J.; Aerts, J.G.J.V.
Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials. Vaccines 2021, 9, 525.
https://doi.org/10.3390/vaccines9050525
AMA Style
Dumoulin DW, Cornelissen R, Bezemer K, Baart SJ, Aerts JGJV.
Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials. Vaccines. 2021; 9(5):525.
https://doi.org/10.3390/vaccines9050525
Chicago/Turabian Style
Dumoulin, Daphne W., Robin Cornelissen, Koen Bezemer, Sara J. Baart, and Joachim G. J. V. Aerts.
2021. "Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials" Vaccines 9, no. 5: 525.
https://doi.org/10.3390/vaccines9050525
APA Style
Dumoulin, D. W., Cornelissen, R., Bezemer, K., Baart, S. J., & Aerts, J. G. J. V.
(2021). Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials. Vaccines, 9(5), 525.
https://doi.org/10.3390/vaccines9050525